Comparison of single-dose and repeated levosimendan infusion in patients with acute exacerbation of advanced heart failure

Creative Commons License

Tasal A., DEMİR M., KANADAŞI M., BACAKSIZ A., Vatankulu M. A., Sahin D. Y., ...More

MEDICAL SCIENCE MONITOR, vol.20, 2014 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 20
  • Publication Date: 2014
  • Doi Number: 10.12659/msm.889767
  • Journal Name: MEDICAL SCIENCE MONITOR
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Bezmialem Vakıf University Affiliated: Yes

Abstract

Background: Levosimendan (LS) is a novel inodilator that improves cardiac performance, central hemodynamics, and symptoms of patients with decompensated chronic heart failure. The aim of this study was to compare the effects of single and repeated LS infusion on left ventricular performance, biomarkers, and neurohormonal activation in patients with acute heart failure.